{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:14:00Z","timestamp":1793952840417,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.npep.2021.102164","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T23:22:56Z","timestamp":1622676176000},"page":"102164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Changes in ghrelin, substance P and vasoactive intestinal peptide levels in the gastroduodenal mucosa of patients with morbid obesity"],"prefix":"10.1016","volume":"89","author":[{"given":"Unal","family":"Atas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuray","family":"Erin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Tazegul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulsum Ozlem","family":"Elpek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.npep.2021.102164_bb0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.npep.2006.07.001","article-title":"Anubhuti. Role of neuropeptides in appetite regulation and obesity--a review","volume":"40","author":"Arora","year":"2006","journal-title":"Neuropeptides."},{"issue":"4","key":"10.1016\/j.npep.2021.102164_bb0010","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0026-0495(91)90143-K","article-title":"A marked decrease of vasoactive intestinal peptide release in obese patients","volume":"40","author":"Baranowska","year":"1991","journal-title":"Metabolism."},{"key":"10.1016\/j.npep.2021.102164_bb0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1749-6632.2000.tb07013.x","article-title":"The role of VIP and somatostatin in the control of GH and prolactin release in anorexia nervosa and in obesity","volume":"921","author":"Baranowska","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.npep.2021.102164_bb0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1463-1326.2000.00070.x","article-title":"Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity","volume":"2","author":"Baranowska","year":"2000","journal-title":"Diabetes Obes. Metab."},{"issue":"5\u20136","key":"10.1016\/j.npep.2021.102164_bb0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000181123","article-title":"Plasma somatostatin and vasoactive intestinal polypeptide responses to an oral mixed test meal in obese patients","volume":"31","author":"Barreca","year":"1989","journal-title":"Horm. Res."},{"issue":"7967","key":"10.1016\/j.npep.2021.102164_bb0030","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(76)91863-8","article-title":"Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance","volume":"1","author":"Bryant","year":"1976","journal-title":"Lancet."},{"key":"10.1016\/j.npep.2021.102164_bb0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.appet.2014.01.011","article-title":"Associations of ghrelin with eating behaviors, stress, metabolic factors, and telomere lengthamong overweight and obese women: preliminary evidence of attenuated ghrelin effects in obesity?","volume":"76","author":"Buss","year":"2014","journal-title":"Appetite"},{"key":"10.1016\/j.npep.2021.102164_bb0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1743-7075-6-32","article-title":"Pre- and post- prandial appetite hormone levels in normal weight and severely obese women","volume":"6","author":"Carlson","year":"2009","journal-title":"Nutr. Metab."},{"issue":"12","key":"10.1016\/j.npep.2021.102164_bb0045","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1038\/oby.2007.355","article-title":"Influence of BMI and gender on postprandial hormone responses","volume":"15","author":"Carroll","year":"2007","journal-title":"Obesity (Silver Spring)"},{"issue":"34","key":"10.1016\/j.npep.2021.102164_bb0050","doi-asserted-by":"crossref","first-page":"26545","DOI":"10.1074\/jbc.M003990200","article-title":"Epidermal growth factor receptor transactivation mediates substance P-induced mitogenic responses in U-373 MG cells","volume":"275","author":"Castagliuolo","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.npep.2021.102164_bb0055","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1111\/j.1572-0241.2006.00832.x","article-title":"Gut-brain neuropeptides in the regulation of ingestive behaviors and obesity","volume":"101","author":"Crowell","year":"2006","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.npep.2021.102164_bb0060","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrendo.2016.222","article-title":"The cellular and molecular bases of leptin and ghrelin resistance in obesity","volume":"13","author":"Cui","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.npep.2021.102164_bb0065","doi-asserted-by":"crossref","first-page":"564457","DOI":"10.3389\/fphar.2020.564457","article-title":"Neurochemistry of enteric neurons following prolonged indomethacin Administration in the Porcine Duodenum","volume":"11","author":"Czajkowska","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.npep.2021.102164_bb0070","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am. J. Surg. Pathol."},{"issue":"4738","key":"10.1016\/j.npep.2021.102164_bb0075","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1126\/science.3511527","article-title":"Obesity, overeating, and rapid gastric emptying in rats with ventromedial hypothalamic lesions","volume":"231","author":"Duggan","year":"1986","journal-title":"Science."},{"issue":"3","key":"10.1016\/j.npep.2021.102164_bb0080","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00535-011-0495-6","article-title":"The proximodistal aggravation of colitis depends on substance P released from TRPV1-expressing sensory neurons","volume":"47","author":"Engel","year":"2012","journal-title":"J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.npep.2021.102164_bb0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2144\/04372ST04","article-title":"Parameters affecting substance P measurement in heart, lung, and skin","volume":"37","author":"Erin","year":"2004","journal-title":"Biotechniques."},{"issue":"1\u20133","key":"10.1016\/j.npep.2021.102164_bb0090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.regpep.2008.10.006","article-title":"Differentiation of neuronal from non-neuronal substance P","volume":"152","author":"Erin","year":"2009","journal-title":"Regul. Pept."},{"issue":"3","key":"10.1016\/j.npep.2021.102164_bb0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0030-1261965","article-title":"Substance P is associated with the development of obesity, chronic inflammation and type 2diabetes mellitus","volume":"119","author":"Fu","year":"2011","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"1","key":"10.1016\/j.npep.2021.102164_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1743-7075-11-3","article-title":"Effects of gastrointestinal motility on obesity","volume":"11","author":"Fu","year":"2014","journal-title":"Nutr. Metab. (Lond.)"},{"issue":"10","key":"10.1016\/j.npep.2021.102164_bb0105","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s11695-007-9221-0","article-title":"Implications of altered gastrointestinal motility in obesity","volume":"17","author":"Gallagher","year":"2007","journal-title":"Obes. Surg."},{"issue":"2","key":"10.1016\/j.npep.2021.102164_bb0110","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0022-3565(25)13040-1","article-title":"Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: evidence from the use of selective VIP antagonists and VIP antiserum","volume":"253","author":"Grider","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2021.102164_bb0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1476-5381.2012.01871.x","article-title":"Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1","volume":"166","author":"Harmar","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.npep.2021.102164_bb0120","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1124\/mol.106.024422","article-title":"Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor","volume":"70","author":"Holst","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.npep.2021.102164_bb0125","first-page":"173","article-title":"Tachykinins in the gut. Part I. expression, release and motor function","volume":"73","author":"Holzer","year":"1997","journal-title":"Farmakol. Ther."},{"issue":"3","key":"10.1016\/j.npep.2021.102164_bb0130","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1006\/bbrc.2000.4039","article-title":"Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue","volume":"279","author":"Hosoda","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.npep.2021.102164_bb0135","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1053\/j.gastro.2007.12.032","article-title":"Substance P as a novel anti-obesity target","volume":"134","author":"Karagiannides","year":"2008","journal-title":"Gastroenterology."},{"issue":"6","key":"10.1016\/j.npep.2021.102164_bb0140","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1210\/en.2010-1345","article-title":"Substance P (SP)-neurokinin-1 receptor (NK-1R) alters adipose tissue responses to high-fat dietand insulin action","volume":"152","author":"Karagiannides","year":"2011","journal-title":"Endocrinology."},{"issue":"4","key":"10.1016\/j.npep.2021.102164_bb0145","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1152\/ajpgi.00162.2012","article-title":"Substance P decreases fat storage and increases adipocytokine production in 3T3-L1 adipocytes","volume":"304","author":"Miegueu","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.npep.2021.102164_bb0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0167-0115(85)90064-3","article-title":"Meal stimulated levels of pancreatic polypeptide (PP) and vasoactive intestinal polypeptide (VIP) in gastroplasty for morbid obesity","volume":"12","author":"Miskowiak","year":"1985","journal-title":"Regul. Pept."},{"issue":"12","key":"10.1016\/j.npep.2021.102164_bb0155","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1002\/jcb.26134","article-title":"Immunolocalization of substance P and NK-1 receptor in ADIPOSE stem cells","volume":"118","author":"Mu\u00f1oz","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.npep.2021.102164_bb0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jcp.20061","article-title":"The role of substance P in inflammatory disease","volume":"201","author":"O\u2019Connor","year":"2004","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.npep.2021.102164_bb0165","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/hel.12065","article-title":"Helicobacter pylori infection associates with a mucosal downregulation of ghrelin, negative regulator of Th1-cell responses","volume":"18","author":"Paoluzi","year":"2013","journal-title":"Helicobacter."},{"issue":"3","key":"10.1016\/j.npep.2021.102164_bb0170","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3748\/wjg.v20.i3.639","article-title":"Impairment of ghrelin synthesis in helicobacter pylori-colonized stomach: new clues for the pathogenesis of H. pylori-related gastric inflammation","volume":"20","author":"Paoluzi","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.npep.2021.102164_bb0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4081\/885","article-title":"Immunolocalisation of vasoactive intestinal peptide and substance P in the developing gut of Dicentrarchus labrax (L.)","volume":"48","author":"Pederzoli","year":"2004","journal-title":"Eur. J. Histochem."},{"issue":"11","key":"10.1016\/j.npep.2021.102164_bb0180","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1210\/en.2008-1638","article-title":"In vivo characterization of high basal signaling from the ghrelin receptor","volume":"150","author":"Petersen","year":"2009","journal-title":"Endocrinology."},{"key":"10.1016\/j.npep.2021.102164_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.npep.2015.02.002","article-title":"Chronic overproduction of ghrelin in the hypothalamus leads to temporal increase in food intake and body weight","volume":"50","author":"Qi","year":"2015","journal-title":"Neuropeptides."},{"issue":"1","key":"10.1016\/j.npep.2021.102164_bb0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/all.12052","article-title":"Substance P antagonist improves both obesity and asthma in a mouse model","volume":"68","author":"Ramalho","year":"2013","journal-title":"Allergy."},{"key":"10.1016\/j.npep.2021.102164_bb0195","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fendo.2018.00090","article-title":"Presence and effects of pituitary adenylate cyclase activating polypeptide under physiological and pathological conditions in the stomach","volume":"9","author":"Reglodi","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.npep.2021.102164_bb0200","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0304-3940(91)90537-4","article-title":"Ruthenium red selectively antagonizes capsaicin-induced release of vasoactive intestinal polypeptide (VIP) from the human colon","volume":"126","author":"Renzi","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2021.102164_bb0205","first-page":"1473","article-title":"Effects of substance P on human colonic mucosa in vitro","volume":"276","author":"Riegler","year":"1999","journal-title":"Am. J. Phys."},{"issue":"6","key":"10.1016\/j.npep.2021.102164_bb0210","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/nmo.12773","article-title":"Gastric ghrelin, GOAT, leptin, and leptinR expression as well as peripheral serotonin are dysregulated in humans with obesity","volume":"28","author":"Ritze","year":"2016","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.npep.2021.102164_bb0215","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0303-7207(82)90092-2","article-title":"A new neuroregulator: the vasoactive intestinal peptide or VIP","volume":"27","author":"Rosselin","year":"1982","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.npep.2021.102164_bb0220","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF03348097","article-title":"Vasoactive intestinal peptide","volume":"9","author":"Said","year":"1986","journal-title":"J. Endocrinol. Investig."},{"issue":"3","key":"10.1016\/j.npep.2021.102164_bb0225","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0196-9781(01)00633-7","article-title":"Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract","volume":"23","author":"Sakata","year":"2002","journal-title":"Peptides."},{"issue":"1","key":"10.1016\/j.npep.2021.102164_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.npep.2021.102164_bb0235","series-title":"Pituitary Adenylate Cyclase Activating Polypeptide \u2014 PACAP. Current Topics in Neurotoxicity","first-page":"261","article-title":"PACAP regulation of gastrointestinal function and obesity","volume":"vol 11; Chapter 16","author":"Vu","year":"2016"},{"key":"10.1016\/j.npep.2021.102164_bb0240","author":"World Health Organization"},{"issue":"11","key":"10.1016\/j.npep.2021.102164_bb0245","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/oby.2004.213","article-title":"Alterations of gastrointestinal motility in obesity","volume":"12","author":"Xing","year":"2004","journal-title":"Obes. Res."},{"key":"10.1016\/j.npep.2021.102164_bb0250","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3945\/jn.109.104406","article-title":"Impaired ghrelin response after high-fat meals is associated with decreased satiety in obese and lean Chinese young adults","volume":"139","author":"Yang","year":"2009","journal-title":"J. Nutr."},{"issue":"6","key":"10.1016\/j.npep.2021.102164_bb0255","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1177\/0300060519844401","article-title":"Serum substance P and vasoactive intestinal peptide levels in infants with acute intussusception","volume":"47","author":"Zhu","year":"2019","journal-title":"J. Int. Med. Res."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417921000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417921000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:37:44Z","timestamp":1758919064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417921000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":51,"alternative-id":["S0143417921000500"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2021.102164","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in ghrelin, substance P and vasoactive intestinal peptide levels in the gastroduodenal mucosa of patients with morbid obesity","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2021.102164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102164"}}